UniProtKB - Q04206 (TF65_HUMAN)
(max 400 entries)x
Your basket is currently empty.
Select item(s) and click on "Add to basket" to create your own collection here
(400 entries max)
Protein
Transcription factor p65
Gene
RELA
Organism
Homo sapiens (Human)
Status
Functioni
NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p50 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric p65-p50 and p65-c-Rel complexes are transcriptional activators. The NF-kappa-B p65-p65 complex appears to be involved in invasin-mediated activation of IL-8 expression. The inhibitory effect of I-kappa-B upon NF-kappa-B the cytoplasm is exerted primarily through the interaction with p65. p65 shows a weak DNA-binding site which could contribute directly to DNA binding in the NF-kappa-B complex. Associates with chromatin at the NF-kappa-B promoter region via association with DDX1. Essential for cytokine gene expression in T-cells (PubMed:15790681).8 Publications
GO - Molecular functioni
- actinin binding Source: UniProtKB
- activating transcription factor binding Source: BHF-UCL
- ankyrin repeat binding Source: Ensembl
- chromatin binding Source: UniProtKB
- chromatin DNA binding Source: UniProtKB
- core promoter sequence-specific DNA binding Source: Ensembl
- DNA binding Source: UniProtKB
- histone deacetylase binding Source: UniProtKB
- identical protein binding Source: UniProtKB
- NF-kappaB binding Source: UniProtKB
- phosphate ion binding Source: UniProtKB
- protein complex binding Source: Ensembl
- protein heterodimerization activity Source: UniProtKB
- protein homodimerization activity Source: UniProtKB
- protein kinase binding Source: UniProtKB
- protein N-terminus binding Source: UniProtKB
- repressing transcription factor binding Source: BHF-UCL
- RNA polymerase II core promoter proximal region sequence-specific DNA binding Source: NTNU_SB
- RNA polymerase II distal enhancer sequence-specific DNA binding Source: NTNU_SB
- RNA polymerase II regulatory region sequence-specific DNA binding Source: UniProtKB
- transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding Source: NTNU_SB
- transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding Source: NTNU_SB
- transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding Source: NTNU_SB
- transcription factor activity, RNA polymerase II core promoter sequence-specific Source: BHF-UCL
- transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding Source: UniProtKB
- transcription factor activity, sequence-specific DNA binding Source: UniProtKB
- transcription factor binding Source: UniProtKB
- transcription regulatory region DNA binding Source: UniProtKB
- ubiquitin protein ligase binding Source: UniProtKB
GO - Biological processi
- acetaldehyde metabolic process Source: Ensembl
- aging Source: Ensembl
- animal organ morphogenesis Source: Ensembl
- cellular defense response Source: UniProtKB
- cellular response to hepatocyte growth factor stimulus Source: Ensembl
- cellular response to hydrogen peroxide Source: UniProtKB
- cellular response to interleukin-1 Source: UniProtKB
- cellular response to interleukin-6 Source: BHF-UCL
- cellular response to lipopolysaccharide Source: Ensembl
- cellular response to nicotine Source: BHF-UCL
- cellular response to peptide hormone stimulus Source: BHF-UCL
- cellular response to peptidoglycan Source: UniProtKB
- cellular response to tumor necrosis factor Source: UniProtKB
- cytokine-mediated signaling pathway Source: UniProtKB
- defense response to virus Source: UniProtKB
- Fc-epsilon receptor signaling pathway Source: Reactome
- hair follicle development Source: Ensembl
- inflammatory response Source: UniProtKB
- liver development Source: Ensembl
- membrane protein intracellular domain proteolysis Source: Reactome
- negative regulation of apoptotic process Source: UniProtKB
- negative regulation of extrinsic apoptotic signaling pathway Source: BHF-UCL
- negative regulation of insulin receptor signaling pathway Source: Ensembl
- negative regulation of NIK/NF-kappaB signaling Source: UniProtKB
- negative regulation of protein catabolic process Source: Ensembl
- negative regulation of transcription, DNA-templated Source: UniProtKB
- negative regulation of transcription from RNA polymerase II promoter Source: NTNU_SB
- nucleotide-binding oligomerization domain containing 2 signaling pathway Source: MGI
- positive regulation of cell proliferation Source: UniProtKB
- positive regulation of chondrocyte differentiation Source: Ensembl
- positive regulation of I-kappaB kinase/NF-kappaB signaling Source: UniProtKB
- positive regulation of interleukin-12 biosynthetic process Source: Ensembl
- positive regulation of miRNA metabolic process Source: BHF-UCL
- positive regulation of NF-kappaB transcription factor activity Source: MGI
- positive regulation of NIK/NF-kappaB signaling Source: CAFA
- positive regulation of pri-miRNA transcription from RNA polymerase II promoter Source: BHF-UCL
- positive regulation of Schwann cell differentiation Source: Ensembl
- positive regulation of T cell receptor signaling pathway Source: CAFA
- positive regulation of transcription, DNA-templated Source: UniProtKB
- positive regulation of transcription from RNA polymerase II promoter Source: UniProtKB
- positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus Source: UniProtKB
- positive regulation of type I interferon production Source: Reactome
- regulation of inflammatory response Source: UniProtKB
- regulation of NIK/NF-kappaB signaling Source: CAFA
- regulation of transcription, DNA-templated Source: CAFA
- response to amino acid Source: Ensembl
- response to cAMP Source: Ensembl
- response to cobalamin Source: Ensembl
- response to drug Source: Ensembl
- response to insulin Source: Ensembl
- response to interleukin-1 Source: BHF-UCL
- response to morphine Source: Ensembl
- response to muramyl dipeptide Source: Ensembl
- response to muscle stretch Source: Ensembl
- response to organic substance Source: UniProtKB
- response to progesterone Source: Ensembl
- response to UV-B Source: UniProtKB
- stimulatory C-type lectin receptor signaling pathway Source: Reactome
- T cell receptor signaling pathway Source: Reactome
- tumor necrosis factor-mediated signaling pathway Source: CAFA
- viral process Source: UniProtKB-KW
Keywordsi
| Molecular function | Activator, DNA-binding |
| Biological process | Host-virus interaction, Transcription, Transcription regulation |
Enzyme and pathway databases
| Reactomei | R-HSA-1169091. Activation of NF-kappaB in B cells. R-HSA-1810476. RIP-mediated NFkB activation via ZBP1. R-HSA-193692. Regulated proteolysis of p75NTR. R-HSA-202424. Downstream TCR signaling. R-HSA-209560. NF-kB is activated and signals survival. R-HSA-2559582. Senescence-Associated Secretory Phenotype (SASP). R-HSA-2871837. FCERI mediated NF-kB activation. R-HSA-3134963. DEx/H-box helicases activate type I IFN and inflammatory cytokines production. R-HSA-3214841. PKMTs methylate histone lysines. R-HSA-381340. Transcriptional regulation of white adipocyte differentiation. R-HSA-445989. TAK1 activates NFkB by phosphorylation and activation of IKKs complex. R-HSA-446652. Interleukin-1 signaling. R-HSA-448706. Interleukin-1 processing. R-HSA-5603027. IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR). R-HSA-5603029. IkBA variant leads to EDA-ID. R-HSA-5607761. Dectin-1 mediated noncanonical NF-kB signaling. R-HSA-5607764. CLEC7A (Dectin-1) signaling. R-HSA-5621575. CD209 (DC-SIGN) signaling. R-HSA-5660668. CLEC7A/inflammasome pathway. R-HSA-933542. TRAF6 mediated NF-kB activation. |
| SABIO-RKi | Q04206. |
| SignaLinki | Q04206. |
| SIGNORi | Q04206. |
Names & Taxonomyi
| Protein namesi | Recommended name: Transcription factor p65Alternative name(s): Nuclear factor NF-kappa-B p65 subunit Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3 |
| Gene namesi | Name:RELA Synonyms:NFKB3 |
| Organismi | Homo sapiens (Human) |
| Taxonomic identifieri | 9606 [NCBI] |
| Taxonomic lineagei | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
| Proteomesi |
|
Organism-specific databases
| HGNCi | HGNC:9955. RELA. |
Subcellular locationi
GO - Cellular componenti
- cytoplasm Source: UniProtKB
- cytosol Source: UniProtKB
- I-kappaB/NF-kappaB complex Source: GO_Central
- NF-kappaB p50/p65 complex Source: CAFA
- nuclear chromatin Source: BHF-UCL
- nucleoplasm Source: Reactome
- nucleus Source: UniProtKB
- transcription factor complex Source: UniProtKB
Keywords - Cellular componenti
Cytoplasm, NucleusPathology & Biotechi
Involvement in diseasei
A chromosomal aberration involving C11orf95 is found in more than two-thirds of supratentorial ependymomas. Translocation with C11orf95 produces a C11orf95-RELA fusion protein. C11orf95-RELA translocations are potent oncogenes that probably transform neural stem cells by driving an aberrant NF-kappa-B transcription program (PubMed:24553141).1 Publication
Mutagenesis
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Mutagenesisi | 254 | T → A: Abolishes interaction with PIN1. 1 Publication | 1 | |
| Mutagenesisi | 276 | S → C: Loss of phosphorylation. 1 Publication | 1 |
Organism-specific databases
| DisGeNETi | 5970. |
| MalaCardsi | RELA. |
| OpenTargetsi | ENSG00000173039. |
| Orphaneti | 251636. Ependymoma. |
| PharmGKBi | PA296. |
Chemistry databases
| ChEMBLi | CHEMBL5533. |
Polymorphism and mutation databases
| BioMutai | RELA. |
| DMDMi | 62906901. |
PTM / Processingi
Molecule processing
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| ChainiPRO_0000205169 | 1 – 551 | Transcription factor p65Add BLAST | 551 |
Amino acid modifications
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Modified residuei | 1 | N-acetylmethionineCombined sources | 1 | |
| Cross-linki | 37 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO3)1 Publication | ||
| Modified residuei | 38 | Cysteine persulfide; alternateBy similarity | 1 | |
| Modified residuei | 38 | S-nitrosocysteine; alternateBy similarity | 1 | |
| Modified residuei | 122 | N6-acetyllysine; by PCAF and EP300; alternate1 Publication | 1 | |
| Cross-linki | 122 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO3); alternate | ||
| Modified residuei | 123 | N6-acetyllysine; by PCAF and EP300; alternate1 Publication | 1 | |
| Cross-linki | 123 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO3); alternate | ||
| Modified residuei | 218 | N6-acetyllysine1 Publication | 1 | |
| Modified residuei | 221 | N6-acetyllysine1 Publication | 1 | |
| Modified residuei | 254 | Phosphothreonine1 Publication | 1 | |
| Modified residuei | 276 | Phosphoserine; by RPS6KA4 and RPS6KA51 Publication | 1 | |
| Modified residuei | 281 | Phosphoserine1 Publication | 1 | |
| Modified residuei | 310 | N6-acetyllysine; alternateCombined sources4 Publications | 1 | |
| Modified residuei | 310 | N6-methyllysine; by SETD6; alternateBy similarity | 1 | |
| Modified residuei | 311 | Phosphoserine; by PKC/PRKCZBy similarity | 1 | |
| Modified residuei | 435 | Phosphothreonine1 Publication | 1 | |
| Modified residuei | 468 | Phosphoserine; by IKKB and IKKE2 Publications | 1 | |
| Modified residuei | 505 | Phosphothreonine; by CHEK11 Publication | 1 | |
| Modified residuei | 529 | Phosphoserine; by CK21 Publication | 1 | |
| Modified residuei | 536 | Phosphoserine; by IKKB2 Publications | 1 |
Post-translational modificationi
Ubiquitinated, leading to its proteasomal degradation. Degradation is required for termination of NF-kappa-B response.1 Publication
Monomethylated at Lys-310 by SETD6. Monomethylation at Lys-310 is recognized by the ANK repeats of EHMT1 and promotes the formation of repressed chromatin at target genes, leading to down-regulation of NF-kappa-B transcription factor activity. Phosphorylation at Ser-311 disrupts the interaction with EHMT1 without preventing monomethylation at Lys-310 and relieves the repression of target genes (By similarity).By similarity
Phosphorylation at Ser-311 disrupts the interaction with EHMT1 and promotes transcription factor activity (By similarity). Phosphorylation on Ser-536 stimulates acetylation on Lys-310 and interaction with CBP; the phosphorylated and acetylated forms show enhanced transcriptional activity. Phosphorylation at Ser-276 by RPS6KA4 and RPS6KA5 promotes its transactivation and transcriptional activities.By similarity14 Publications
Reversibly acetylated; the acetylation seems to be mediated by CBP, the deacetylation by HDAC3 and SIRT2. Acetylation at Lys-122 enhances DNA binding and impairs association with NFKBIA. Acetylation at Lys-310 is required for full transcriptional activity in the absence of effects on DNA binding and NFKBIA association. Acetylation at Lys-310 promotes interaction with BRD4. Acetylation can also lower DNA-binding and results in nuclear export. Interaction with BRMS1 promotes deacetylation of Lys-310. Lys-310 is deacetylated by SIRT2.5 Publications
S-nitrosylation of Cys-38 inactivates the enzyme activity.By similarity
Sulfhydration at Cys-38 mediates the anti-apoptotic activity by promoting the interaction with RPS3 and activating the transcription factor activity.By similarity
Sumoylation by PIAS3 negatively regulates DNA-bound activated NF-kappa-B.1 Publication
Proteolytically cleaved within a conserved N-terminus region required for base-specific contact with DNA in a CPEN1-mediated manner, and hence inhibits NF-kappa-B transcriptional activity (PubMed:18212740).1 Publication
Keywords - PTMi
Acetylation, Isopeptide bond, Methylation, Phosphoprotein, S-nitrosylation, Ubl conjugationProteomic databases
| EPDi | Q04206. |
| MaxQBi | Q04206. |
| PaxDbi | Q04206. |
| PeptideAtlasi | Q04206. |
| PRIDEi | Q04206. |
PTM databases
| iPTMneti | Q04206. |
| PhosphoSitePlusi | Q04206. |
| SwissPalmi | Q04206. |
Expressioni
Gene expression databases
| Bgeei | ENSG00000173039. |
| CleanExi | HS_RELA. |
| ExpressionAtlasi | Q04206. baseline and differential. |
| Genevisiblei | Q04206. HS. |
Organism-specific databases
| HPAi | CAB004264. CAB005030. HPA063461. |
Interactioni
Subunit structurei
Component of the NF-kappa-B p65-p50 complex. Component of the NF-kappa-B p65-c-Rel complex. Homodimer; component of the NF-kappa-B p65-p65 complex. Component of the NF-kappa-B p65-p52 complex. May interact with ETHE1. Binds AES and TLE1. Interacts with TP53BP2. Binds to and is phosphorylated by the activated form of either RPS6KA4 or RPS6KA5. Interacts with ING4 and this interaction may be indirect. Interacts with CARM1, USP48 and UNC5CL. Interacts with IRAK1BP1 (By similarity). Interacts with NFKBID (By similarity). Interacts with NFKBIA. Interacts with GSK3B. Interacts with NFKBIB (By similarity). Interacts with NFKBIE. Interacts with NFKBIZ. Interacts with EHMT1 (via ANK repeats) (By similarity). Part of a 70-90 kDa complex at least consisting of CHUK, IKBKB, NFKBIA, RELA, IKBKAP and MAP3K14. Interacts with HDAC3; HDAC3 mediates the deacetylation of RELA. Interacts with HDAC1; the interaction requires non-phosphorylated RELA. Interacts with CBP; the interaction requires phosphorylated RELA. Interacts (phosphorylated at 'Thr-254') with PIN1; the interaction inhibits p65 binding to NFKBIA. Interacts with SOCS1. Interacts with UXT. Interacts with MTDH and PHF11. Interacts with ARRB2. Interacts with human respiratory syncytial virus (HRSV) protein M2-1. Interacts with NFKBIA (when phosphorylated), the interaction is direct; phosphorylated NFKBIA is part of a SCF(BTRC)-like complex lacking CUL1. Interacts with RNF25. Interacts (via C-terminus) with DDX1. Interacts with UFL1 and COMMD1. Interacts with BRMS1; this promotes deacetylation of 'Lys-310'. Interacts with NOTCH2 (By similarity). Directly interacts with MEN1; this interaction represses NFKB-mediated transactivation. Interacts with AKIP1, which promotes the phosphorylation and nuclear retention of RELA. Interacts (via the RHD) with GFI1; the interaction, after bacterial lipopolysaccharide (LPS) stimulation, inhibits the transcriptional activity by interfering with the DNA-binding activity to target gene promoter DNA. Interacts (when acetylated at Lys-310) with BRD4; leading to activation of the NF-kappa-B pathway. Interacts with MEFV. Interacts with CLOCK (By similarity). Interacts (via N-terminus) with CPEN1; this interaction induces proteolytic cleavage of p65/RELA subunit and inhibition of NF-kappa-B transcriptional activity (PubMed:18212740). Interacts with FOXP3. Interacts with CDK5RAP3; stimulates the interaction of RELA with HDAC1, HDAC2 and HDAC3 thereby inhibiting NF-kappa-B transcriptional activity (PubMed:17785205).By similarity3 Publications
Binary interactionsi
GO - Molecular functioni
- actinin binding Source: UniProtKB
- activating transcription factor binding Source: BHF-UCL
- ankyrin repeat binding Source: Ensembl
- histone deacetylase binding Source: UniProtKB
- identical protein binding Source: UniProtKB
- NF-kappaB binding Source: UniProtKB
- protein complex binding Source: Ensembl
- protein heterodimerization activity Source: UniProtKB
- protein homodimerization activity Source: UniProtKB
- protein kinase binding Source: UniProtKB
- protein N-terminus binding Source: UniProtKB
- repressing transcription factor binding Source: BHF-UCL
- transcription factor binding Source: UniProtKB
- ubiquitin protein ligase binding Source: UniProtKB
Protein-protein interaction databases
| BioGridi | 111902. 275 interactors. |
| DIPi | DIP-24238N. |
| IntActi | Q04206. 135 interactors. |
| MINTi | MINT-106444. |
| STRINGi | 9606.ENSP00000384273. |
Chemistry databases
| BindingDBi | Q04206. |
Structurei
Secondary structure
Legend: HelixTurnBeta strandPDB Structure known for this area
Show more details| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Beta strandi | 21 – 25 | Combined sources | 5 | |
| Beta strandi | 30 – 32 | Combined sources | 3 | |
| Beta strandi | 39 – 41 | Combined sources | 3 | |
| Beta strandi | 53 – 55 | Combined sources | 3 | |
| Beta strandi | 60 – 63 | Combined sources | 4 | |
| Beta strandi | 68 – 80 | Combined sources | 13 | |
| Beta strandi | 87 – 92 | Combined sources | 6 | |
| Beta strandi | 97 – 104 | Combined sources | 8 | |
| Beta strandi | 109 – 112 | Combined sources | 4 | |
| Beta strandi | 117 – 119 | Combined sources | 3 | |
| Helixi | 123 – 125 | Combined sources | 3 | |
| Helixi | 126 – 129 | Combined sources | 4 | |
| Turni | 130 – 137 | Combined sources | 8 | |
| Turni | 145 – 148 | Combined sources | 4 | |
| Beta strandi | 156 – 166 | Combined sources | 11 | |
| Beta strandi | 168 – 173 | Combined sources | 6 | |
| Beta strandi | 183 – 188 | Combined sources | 6 | |
| Beta strandi | 196 – 200 | Combined sources | 5 | |
| Beta strandi | 202 – 205 | Combined sources | 4 | |
| Beta strandi | 211 – 217 | Combined sources | 7 | |
| Beta strandi | 225 – 230 | Combined sources | 6 | |
| Beta strandi | 233 – 238 | Combined sources | 6 | |
| Helixi | 241 – 243 | Combined sources | 3 | |
| Turni | 246 – 248 | Combined sources | 3 | |
| Beta strandi | 249 – 253 | Combined sources | 5 | |
| Beta strandi | 258 – 260 | Combined sources | 3 | |
| Beta strandi | 266 – 273 | Combined sources | 8 | |
| Turni | 275 – 277 | Combined sources | 3 | |
| Beta strandi | 284 – 289 | Combined sources | 6 | |
| Helixi | 294 – 302 | Combined sources | 9 | |
| Helixi | 309 – 311 | Combined sources | 3 | |
| Helixi | 313 – 323 | Combined sources | 11 | |
| Beta strandi | 330 – 335 | Combined sources | 6 | |
| Beta strandi | 338 – 342 | Combined sources | 5 | |
| Helixi | 358 – 360 | Combined sources | 3 | |
| Helixi | 361 – 369 | Combined sources | 9 | |
| Helixi | 388 – 406 | Combined sources | 19 | |
| Beta strandi | 528 – 530 | Combined sources | 3 | |
| Helixi | 532 – 536 | Combined sources | 5 | |
| Helixi | 537 – 546 | Combined sources | 10 |
3D structure databases
| Select the link destinations: PDBei RCSB PDBi PDBji Links Updated | PDB entry | Method | Resolution (Å) | Chain | Positions | PDBsum |
| 1NFI | X-ray | 2.70 | A/C | 20-320 | [»] | |
| 2LSP | NMR | - | A | 304-316 | [»] | |
| 2O61 | X-ray | 2.80 | A | 20-291 | [»] | |
| 3GUT | X-ray | 3.59 | A/C/E/G | 20-291 | [»] | |
| 3QXY | X-ray | 2.09 | P/Q | 302-316 | [»] | |
| 3RC0 | X-ray | 2.19 | P/Q | 302-316 | [»] | |
| 4KV1 | X-ray | 1.50 | C/D | 308-314 | [»] | |
| 4KV4 | X-ray | 2.00 | B | 308-314 | [»] | |
| 5U4K | NMR | - | B | 521-551 | [»] | |
| 5URN | NMR | - | B | 521-551 | [»] | |
| DisProti | DP00085. | |||||
| ProteinModelPortali | Q04206. | |||||
| SMRi | Q04206. | |||||
| ModBasei | Search... | |||||
| MobiDBi | Search... | |||||
Miscellaneous databases
| EvolutionaryTracei | Q04206. |
Family & Domainsi
Domains and Repeats
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Domaini | 19 – 306 | RHDPROSITE-ProRule annotationAdd BLAST | 288 |
Region
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Regioni | 415 – 459 | Activation domainAdd BLAST | 45 |
Motif
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Motifi | 301 – 304 | Nuclear localization signalSequence analysis | 4 | |
| Motifi | 536 – 544 | 9aaTAD | 9 |
Domaini
the 9aaTAD motif is a transactivation domain present in a large number of yeast and animal transcription factors.1 Publication
Phylogenomic databases
| eggNOGi | ENOG410IG8F. Eukaryota. ENOG410XT64. LUCA. |
| GeneTreei | ENSGT00500000044765. |
| HOGENOMi | HOG000230474. |
| HOVERGENi | HBG017916. |
| InParanoidi | Q04206. |
| KOi | K04735. |
| OMAi | EFSPMVF. |
| OrthoDBi | EOG091G08JD. |
| PhylomeDBi | Q04206. |
| TreeFami | TF325632. |
Family and domain databases
| CDDi | cd01177. IPT_NFkappaB. 1 hit. |
| Gene3Di | 2.60.40.10. 1 hit. 2.60.40.340. 1 hit. |
| InterProi | View protein in InterPro IPR013783. Ig-like_fold. IPR014756. Ig_E-set. IPR002909. IPT. IPR033926. IPT_NFkappaB. IPR000451. NFkB/Dor. IPR008967. p53-like_TF_DNA-bd. IPR030495. RelA. IPR030492. RHD_CS. IPR032397. RHD_dimer. IPR011539. RHD_DNA_bind_dom. |
| PANTHERi | PTHR24169. PTHR24169. 1 hit. PTHR24169:SF23. PTHR24169:SF23. 1 hit. |
| Pfami | View protein in Pfam PF16179. RHD_dimer. 1 hit. PF00554. RHD_DNA_bind. 1 hit. |
| PRINTSi | PR00057. NFKBTNSCPFCT. |
| SMARTi | View protein in SMART SM00429. IPT. 1 hit. |
| SUPFAMi | SSF49417. SSF49417. 1 hit. SSF81296. SSF81296. 1 hit. |
| PROSITEi | View protein in PROSITE PS01204. REL_1. 1 hit. PS50254. REL_2. 1 hit. |
Sequences (4)i
Sequence statusi: Complete.
This entry describes 4 isoformsi produced by alternative splicing. AlignAdd to basket
Isoform 1 (identifier: Q04206-1) [UniParc]FASTAAdd to basket
Also known as: p65
This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
10 20 30 40 50
MDELFPLIFP AEPAQASGPY VEIIEQPKQR GMRFRYKCEG RSAGSIPGER
60 70 80 90 100
STDTTKTHPT IKINGYTGPG TVRISLVTKD PPHRPHPHEL VGKDCRDGFY
110 120 130 140 150
EAELCPDRCI HSFQNLGIQC VKKRDLEQAI SQRIQTNNNP FQVPIEEQRG
160 170 180 190 200
DYDLNAVRLC FQVTVRDPSG RPLRLPPVLS HPIFDNRAPN TAELKICRVN
210 220 230 240 250
RNSGSCLGGD EIFLLCDKVQ KEDIEVYFTG PGWEARGSFS QADVHRQVAI
260 270 280 290 300
VFRTPPYADP SLQAPVRVSM QLRRPSDREL SEPMEFQYLP DTDDRHRIEE
310 320 330 340 350
KRKRTYETFK SIMKKSPFSG PTDPRPPPRR IAVPSRSSAS VPKPAPQPYP
360 370 380 390 400
FTSSLSTINY DEFPTMVFPS GQISQASALA PAPPQVLPQA PAPAPAPAMV
410 420 430 440 450
SALAQAPAPV PVLAPGPPQA VAPPAPKPTQ AGEGTLSEAL LQLQFDDEDL
460 470 480 490 500
GALLGNSTDP AVFTDLASVD NSEFQQLLNQ GIPVAPHTTE PMLMEYPEAI
510 520 530 540 550
TRLVTGAQRP PDPAPAPLGA PGLPNGLLSG DEDFSSIADM DFSALLSQIS
S
Experimental Info
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Sequence conflicti | 49 | E → R in CAA80524 (PubMed:8281153).Curated | 1 | |
| Sequence conflicti | 180 | S → P in AAA36408 (PubMed:2006423).Curated | 1 | |
| Sequence conflicti | 372 – 380 | QISQASALA → RSARPRLG in CAA80524 (PubMed:8281153).Curated | 9 |
Alternative sequence
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Alternative sequenceiVSP_005587 | 13 – 25 | Missing in isoform 2. 1 PublicationAdd BLAST | 13 | |
| Alternative sequenceiVSP_031245 | 143 – 145 | Missing in isoform 4. 1 Publication | 3 | |
| Alternative sequenceiVSP_012031 | 222 – 231 | Missing in isoform 3. 1 Publication | 10 | |
| Alternative sequenceiVSP_005588 | 506 | Missing in isoform 2. 1 Publication | 1 |
Sequence databases
| Select the link destinations: EMBLi GenBanki DDBJi Links Updated | M62399 mRNA. Translation: AAA36408.1. Z22948 Z22951 Genomic DNA. Translation: CAA80524.2. L19067 mRNA. Translation: AAA20946.1. BC033522 mRNA. Translation: AAH33522.1. AY455868 Genomic DNA. Translation: AAR13863.1. |
| CCDSi | CCDS31609.1. [Q04206-1] CCDS44651.1. [Q04206-4] |
| PIRi | A40851. I53719. S51782. A42017. |
| RefSeqi | NP_001138610.1. NM_001145138.1. [Q04206-4] NP_001230913.1. NM_001243984.1. NP_068810.3. NM_021975.3. [Q04206-1] |
| UniGenei | Hs.502875. |
Genome annotation databases
| Ensembli | ENST00000308639; ENSP00000311508; ENSG00000173039. [Q04206-4] ENST00000406246; ENSP00000384273; ENSG00000173039. [Q04206-1] |
| GeneIDi | 5970. |
| KEGGi | hsa:5970. |
| UCSCi | uc001ofg.4. human. [Q04206-1] |
Keywords - Coding sequence diversityi
Alternative splicing, Chromosomal rearrangementSimilar proteinsi
Links to similar proteins from the UniProt Reference Clusters (UniRef) at 100%, 90% and 50% sequence identity:| 100% | UniRef100 combines identical sequences and sub-fragments with 11 or more residues from any organism into one UniRef entry. |
| 90% | UniRef90 is built by clustering UniRef100 sequences that have at least 90% sequence identity to, and 80% overlap with, the longest sequence (a.k.a seed sequence). |
| 50% | UniRef50 is built by clustering UniRef90 seed sequences that have at least 50% sequence identity to, and 80% overlap with, the longest sequence in the cluster. |
Entry informationi
| Entry namei | TF65_HUMAN | |
| Accessioni | Q04206Primary (citable) accession number: Q04206 Secondary accession number(s): Q6GTV1, Q6SLK1 | |
| Entry historyi | Integrated into UniProtKB/Swiss-Prot: | October 1, 1993 |
| Last sequence update: | April 26, 2005 | |
| Last modified: | July 5, 2017 | |
| This is version 209 of the entry and version 2 of the sequence. See complete history. | ||
| Entry statusi | Reviewed (UniProtKB/Swiss-Prot) | |
| Annotation program | Chordata Protein Annotation Program | |
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | |
Miscellaneousi
Keywords - Technical termi
3D-structure, Complete proteome, Reference proteomeDocuments
- Human chromosome 11
Human chromosome 11: entries, gene names and cross-references to MIM - MIM cross-references
Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot - PDB cross-references
Index of Protein Data Bank (PDB) cross-references
